Cortex Volume Change
Introduction
Cortex volume change refers to alterations in the size and thickness of the cerebral cortex, the outermost layer of the brain responsible for higher-order functions such as thought, language, memory, and consciousness. The cortex is a highly dynamic structure that undergoes significant development throughout life, from embryonic stages through adulthood and aging. Changes in its volume can reflect various biological processes, including neurodevelopment, neuroplasticity, disease progression, and the effects of environmental factors. Understanding these changes is crucial for comprehending brain health and disease.
Biological Basis
The volume of the cerebral cortex is influenced by a complex interplay of genetic and environmental factors. Brain imaging techniques, such as Magnetic Resonance Imaging (MRI), allow for the detailed measurement of brain structures. Programs like AMIRA and SIENAX are used to analyze MRI scans, segmenting brain and skull images, and calculating total brain volume, often normalized for head size . Smaller cohorts can limit the ability to identify genuine associations and may lead to an overestimation of effect sizes for detected variants, increasing the potential for false-positive findings. [1] The absence of independent replication cohorts further complicates the validation of initial discoveries, making it challenging to confidently distinguish robust genetic associations from those that may have arisen by chance. [1]
Replication challenges are also compounded by variations in study design, population characteristics, and the extent of genetic coverage across different investigations. [2] For example, reliance on earlier, less dense SNP arrays, such as the 100K gene chip, may not provide comprehensive coverage of genetic variation within specific regions, potentially missing true associations or hindering direct comparisons with studies using more extensive platforms. [3] This incomplete genetic coverage can result in a lack of replication at the individual SNP level, even if different variants within the same gene are genuinely associated across diverse cohorts. [2]
Phenotypic Measurement and Confounding Factors
The precise measurement of cortex volume change is critical and typically relies on sophisticated imaging software, such as AMIRA and SIENAX, for accurate brain volume estimation and normalization to individual head size. [4] Although these methods are advanced, they involve complex processes like partial volume estimation and registration to standard anatomical spaces, which can introduce subtle variabilities or potential misclassifications, particularly when attempting to quantify minute changes over time. [4] Such inherent measurement noise can potentially obscure genuine genetic effects or contribute to spurious associations, thereby affecting the overall reliability and interpretability of genetic findings related to brain morphology.
Studies that average phenotypic traits over extended durations, sometimes spanning decades and utilizing different generations of imaging equipment, may inadvertently introduce significant measurement variability and misclassification. [5] Moreover, this averaging approach often presumes that the underlying genetic and environmental influences on cortex volume remain constant across a broad age spectrum, an assumption that may not hold true given the likelihood of age-dependent gene effects. [5] Masking these age-specific genetic interactions could lead to an incomplete or misleading understanding of the genetic architecture governing cortex volume change throughout an individual's lifespan.
Generalizability and Unaccounted Genetic Variation
Genetic association studies, particularly genome-wide approaches, are vulnerable to population stratification, a phenomenon where differences in allele frequencies between ancestral subgroups can lead to spurious associations. [4] While statistical methods such as genomic control and principal component analysis are routinely applied to mitigate this bias, residual effects can sometimes persist, impacting the accuracy and interpretation of findings. [4] Furthermore, research primarily conducted in populations of European descent may not be broadly applicable to other ethnicities, creating a significant gap in understanding the genetic determinants of cortex volume across globally diverse ancestral backgrounds. [5]
Cortex volume change is a complex trait that is likely influenced by intricate interactions between genetic predispositions and various environmental factors, including lifestyle, diet, and psychological stress. [1] However, most research studies do not comprehensively investigate these gene-environment interactions, potentially overlooking crucial modulators of genetic effects and leaving a substantial portion of the trait's heritability unexplained. [5] This limited exploration of complex interactions restricts the ability to fully elucidate the complete genetic architecture and to accurately predict individual differences in cortex volume change.
Variants
Genetic variations play a crucial role in shaping brain structure and function, with specific single nucleotide polymorphisms (SNPs) impacting gene activity and contributing to complex traits like cortex volume change. The variants discussed here are associated with genes involved in fundamental neurodevelopmental processes, synaptic plasticity, cellular maintenance, and gene regulation, all of which are critical for maintaining brain health and integrity. These genetic influences can manifest in subtle alterations in brain morphology or contribute to the risk of neurological and psychiatric conditions.
Variants such as rs62494313 near BIN3 and EGR3, and rs3779289 in MAGI2, are implicated in processes vital for neuronal development and signaling. BIN3 is involved in endocytosis and membrane trafficking, pathways essential for synaptic vesicle recycling and neuronal communication. EGR3 encodes an immediate early gene transcription factor crucial for neuronal plasticity, learning, and memory formation, making variants in this region relevant to how brain circuits adapt and mature. MAGI2 is a scaffolding protein important for organizing synapses and cell adhesion, which are fundamental to establishing and maintaining neuronal connections and overall brain architecture. Disruptions in these genes or their regulatory regions, as indicated by these variants, can influence the precise wiring of the brain during development and its ongoing plasticity, potentially leading to differences in cortex volume or susceptibility to neurodevelopmental disorders. [6] Similarly, rs6435231 near DSTNP5 and PARD3B points to genes involved in cell polarity and asymmetric cell division, processes critical for neural stem cell fate and the precise layering of the cerebral cortex. [7] Meanwhile, rs11356759 in SPTLC1 is associated with serine palmitoyltransferase, an enzyme involved in sphingolipid biosynthesis. Sphingolipids are essential components of neuronal membranes and myelin, and their dysregulation can significantly impact neuronal function and myelin integrity, thereby affecting brain volume and cognitive function.
Other variants affect genes involved in cell structure, protein degradation, and metabolic pathways crucial for neuronal health. rs616642 in COL9A1 is associated with a gene encoding a component of collagen, contributing to the extracellular matrix that provides structural support and influences neuronal migration and connectivity within the brain. Variants like rs12784270 in WDR37 are found in genes involved in diverse cellular processes, including signal transduction and cell cycle regulation, which are critical for the growth and maintenance of brain cells. The variant rs11928098 near CRBN and SUMF1 highlights genes with significant roles in neuronal function. CRBN is a component of an E3 ubiquitin ligase complex, critical for protein degradation, synaptic plasticity, and memory formation, and its dysfunction can impact brain development and cognitive abilities. [6] SUMF1 is essential for activating sulfatase enzymes, which are vital for the breakdown of sulfated molecules, including those found in myelin. Deficiencies can lead to lysosomal storage disorders with severe neurological consequences, impacting brain parenchymal volume and overall brain health. [7]
The influence of non-coding RNA variants, such as rs9635993 near LINC02879 and MIR302F, rs2532765 near LINC01517 and LYZL1, and rs17809993 near MIR3166 and CTSC, underscores the complex regulatory landscape governing brain development. MicroRNAs (miRNAs) like MIR302F and MIR3166 are powerful post-transcriptional regulators of gene expression, influencing neuronal differentiation, synaptic plasticity, and overall brain patterning. Long intergenic non-coding RNAs (lncRNAs) such as LINC02879 and LINC01517 also play critical regulatory roles, affecting gene expression and chromatin structure, which can have profound effects on neurodevelopment and brain function. Changes in the expression or activity of these non-coding RNAs due to specific variants can alter the precise balance of gene products required for healthy brain development and maintenance, potentially contributing to subtle or significant changes in cortex volume. For instance, CTSC encodes a lysosomal protease, and its regulation by MIR3166 could impact lysosomal function, which is essential for cellular waste removal and neuronal health, thereby affecting brain integrity and volume. These regulatory variations contribute to the intricate genetic architecture underlying variations in brain structure and function . [6], [7]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs62494313 | BIN3 - EGR3 | cortex volume change measurement cortical thickness change measurement |
| rs616642 | COL9A1 | cortex volume change measurement |
| rs11356759 | SPTLC1 | cortex volume change measurement |
| rs3779289 | MAGI2 | cortex volume change measurement |
| rs6435231 | DSTNP5 - PARD3B | cortex volume change measurement cortical thickness change measurement |
| rs11928098 | CRBN - SUMF1 | cortex volume change measurement |
| rs12784270 | WDR37 | cortex volume change measurement |
| rs9635993 | LINC02879 - MIR302F | cortex volume change measurement |
| rs2532765 | LINC01517 - LYZL1 | cortex volume change measurement |
| rs17809993 | MIR3166 - CTSC | total brain volume change measurement, age at assessment cortex volume change measurement cortical thickness change measurement, age at assessment |
Definition and Conceptualization of Brain Volume Change
Cortex volume change refers to alterations in the physical size of the cerebral cortex, the outermost layer of the brain crucial for higher cognitive functions such as memory, attention, perception, and language. A decrease in brain volume, specifically termed atrophy, signifies a reduction in brain tissue and is a recognized indicator of neurodegeneration. [4] This phenomenon can occur as part of normal aging or in the context of various neurological and psychiatric conditions.
In scientific research, brain volume change, encompassing cortical changes, is frequently conceptualized as a quantitative trait, allowing for its measurement along a continuous scale rather than a simple categorical presence or absence. [1] This dimensional approach enables a more nuanced understanding of brain structure. Such quantitative traits are often studied as intermediate phenotypes, which are measurable characteristics that lie in the causal pathway between genetic factors and overt clinical diseases. [5]
Measurement Methodologies and Operational Definitions
The assessment of brain volume change primarily relies on advanced neuroimaging techniques, particularly structural magnetic resonance imaging (MRI). [4] High-resolution T1-weighted images are typically acquired, providing detailed anatomical information necessary for accurate tissue differentiation and volume estimation. [4] These images capture the intricate structure of the brain, including the cerebral cortex, white matter, and subcortical structures.
To quantify brain volume, sophisticated computational methods are employed, such as tissue segmentation with partial volume estimation, which distinguishes different tissue types and calculates their respective volumes. [4] Operational definitions for brain volume involve extracting brain and skull images from the structural acquisition and registering the brain image to a standard space, normalizing for individual subject head size. [4] Software packages like SIENAX, a component of the FMRIB Software Library, facilitate the calculation of total brain volume and normalized Brain Parenchymal Volume (nBPV), which serves as an operational measure for cross-sectional assessments of atrophy. [4]
Clinical and Research Significance
Alterations in brain volume, including those affecting the cortex, hold significant clinical relevance across a spectrum of neurological and psychiatric disorders. For example, brain atrophy is a key feature evaluated in conditions such as multiple sclerosis, where it can indicate disease progression and severity. [4] Beyond global brain volume, specific regional volume changes, such as those observed in the corpus callosum in schizophrenia, underscore the importance of localized structural integrity in disease pathophysiology. [8]
In research, brain volume change is a valuable quantitative phenotype utilized in genome-wide association studies (GWAS) to identify genetic loci associated with variations in brain structure. [1] By treating volume as a continuous variable, these studies adopt a dimensional approach to explore the genetic underpinnings and clinical correlates of brain structure, moving beyond simple categorical disease classifications. [1] This enables researchers to characterize intermediate phenotypes that bridge the gap between genetic risk factors and the manifestation of overt disease. [5]
Genetic Predisposition and Neurodevelopment
Cortex volume is significantly influenced by an individual's genetic makeup and the intricate processes of neurodevelopment. Inherited genetic variants play a crucial role, with genome-wide association studies identifying specific genes linked to brain structure and function. For instance, in conditions like schizophrenia, variants in genes such as ROBO1-ROBO2, TNIK, CTXN3-SLC12A2, POU3F2, TRAF3, and GPC1 have been associated with altered brain activation and cortical structure. [1] These genes are integral to forebrain development, neural precursor migration, and axonal connectivity, suggesting that disruptions in these pathways can lead to changes in cortical volume. [1] CTXN3, for example, is a brain-specific protein highly enriched in the cortex, with its expression increasing during perinatal development, while SLC12A2 is involved in GABA neurotransmission and shows differential expression in the dorsolateral prefrontal cortex (DLPFC) of individuals with schizophrenia. [1]
Beyond specific genes, broader genetic influences such as those affecting glutamate signaling pathways are also implicated. In multiple sclerosis, genes like VIP, NPHS2, and KCNK5 have been linked to overall brain parenchymal volume, which includes cortical areas. [4] The developmental trajectory of the cortex, particularly the forebrain and its complex connections, is a sensitive period during which genetic factors can manifest as structural alterations. Abnormal development and connectivity of the DLPFC are well-documented in schizophrenia, contributing to the observed changes in cortical structure. [1] Furthermore, early life influences, including prenatal and postnatal stress, are noted to profoundly affect DLPFC function, thereby potentially impacting cortical development and subsequent volume. [1]
Environmental Influences and Lifestyle Factors
Environmental factors, particularly stress, can significantly impact cortex volume and function. Exposure to chronic or acute stress has been shown to exacerbate symptoms in individuals with serious mental illnesses and can lead to observable dysfunction in the dorsolateral prefrontal cortex (DLPFC). [1] While the specific mechanisms are complex, environmental stressors can trigger physiological responses that directly or indirectly affect neuronal health and cortical integrity. The context highlights the brain's susceptibility to adverse environmental stimuli, indicating that external pressures can contribute to functional and potentially structural changes within cortical regions over time.
Gene-Environment Interactions and Stress Response
The interplay between an individual's genetic predispositions and environmental triggers, especially stress, is a critical determinant of cortex volume and function. Genetic vulnerabilities can dictate how readily an individual's brain responds to and is affected by environmental stressors. For instance, individuals carrying specific genetic variants, such as the met-met form of the COMT gene, may exhibit heightened susceptibility to prefrontal cortical disruption when exposed to stress. [1] Stress induces the release of cortisol, which can inhibit COMT activity in the cortex, leading to an increase in extracellular dopamine levels that can impair prefrontal functioning and contribute to psychiatric symptoms. [1] This mechanism illustrates how an individual's genetic makeup modulates the brain's biochemical response to environmental challenges, directly impacting cortical function and potentially its structure.
The hypothalamus-pituitary-adrenal (HPA) stress axis is a key mediator of these gene-environment interactions. Genes such as TRAF3, TNIK, and POU3F2 are involved in regulating HPA axis function and the brain's responses to environmental stress. [1] TNIK participates in immediate early gene activation pathways in response to stress and influences neuronal responses and long-term potentiation. [1] Similarly, POU3F2 acts as a transcription factor, regulating genes associated with CRH and CRH promoters, which are crucial for cell survival and brain development. [1] These examples underscore how specific genetic pathways can modify an individual's resilience or susceptibility to environmental stressors, ultimately affecting cortical volume and function.
Comorbidities and Age-Related Changes
Cortex volume changes are frequently observed in association with various comorbid conditions. Neurodegenerative and neuropsychiatric disorders are prominent examples where altered cortical structure is a defining feature. Multiple sclerosis, for instance, is characterized by changes in brain parenchymal volume, which often include significant cortical atrophy. [4] Similarly, schizophrenia is strongly linked to abnormal development and connectivity within the dorsolateral prefrontal cortex (DLPFC), leading to measurable differences in cortical structure and function. [1] These conditions themselves act as major contributing factors to variations in cortex volume. The presence of such comorbidities can accelerate or initiate processes that lead to reductions or alterations in cortical tissue. While the provided context does not extensively detail age-related changes as a distinct independent causal factor, the discussion of neurodevelopmental disorders and the perinatal increase in CTXN3 expression suggest that cortical structure undergoes dynamic changes throughout the lifespan, which can be influenced by disease processes.
Cortical Development and Neural Connectivity
The intricate architecture of the cerebral cortex, which underlies higher cognitive functions, is established through precisely regulated neurodevelopmental processes. These processes involve the coordinated migration of neural precursors, the guidance of axons to form complex networks, and the formation of stable cellular adhesions. Genes such as GPC1 (glypican) and ROBO1 and ROBO2 (Roundabout homolog) are crucial for dorsal forebrain development, including neural precursor migration and axonal connectivity, particularly for midline crossing and guidance of axons related to prefrontal cortices. [1] SLIT2, a highly conserved gene, contributes to migratory mechanisms and axonal guidance, a role also observed in vascular function. [5] The brain-specific integral membrane protein CTXN3 (cortexin) is highly enriched in the cortex, with its expression increasing perinatally in the fetal brain, highlighting its role in cortical maturation. [1]
Further contributing to the structural integrity and development of the central nervous system (CNS) are genes like CNTN6 (Contactin 6), PBX1 (Pre-B-cell leukemia transcription factor 1), and PCP4 (Purkinje cell protein 4), which are implicated in general CNS development and cell adhesion. [4] POU3F2, a transcription factor, regulates genes associated with corticotropin-releasing hormone (CRH) and its promoters, influencing cell survival and brain development through its role in neuronal cell differentiation. [1] Disruptions in these fundamental developmental pathways can lead to altered cortical structure and contribute to variations in cortical volume.
Molecular Signaling and Neurotransmission
Cortical function and integrity are profoundly dependent on a sophisticated network of molecular signaling pathways and neurotransmission systems. The glutamate signaling pathway, involving genes like GRIN2A (Glutamate Ionotropic Receptor NMDA Type Subunit 2A) and HOMER2 (Homer Scaffolding Protein 2), is vital for synaptic plasticity and neuronal communication. [4] Similarly, calcium-mediated signaling, influenced by genes such as EGFR (Epidermal Growth Factor Receptor), PIP5K3 (Phosphatidylinositol-4-Phosphate 5-Kinase Type III Alpha), and MCTP2 (Multiple C2 and Transmembrane Domain Containing Protein 2), plays a critical role in neuronal excitability and cellular responses. [4] G-protein signaling, involving DGKG (Diacylglycerol Kinase Gamma), EDNRB (Endothelin Receptor Type B), and again EGFR, mediates diverse cellular processes including cell growth, differentiation, and metabolism. [4]
Neurotransmitter systems, such as GABA neurotransmission, are also crucial, with genes like SLC12A2 (Solute Carrier Family 12 Member 2) being implicated in its regulation and showing differential expression in certain conditions. [1] The hypothalamus-pituitary-adrenal (HPA) stress axis, modulated by genes like TRAF3 (TNF Receptor Associated Factor 3), TNIK (TRAF2 And NCK Interacting Kinase), and POU3F2, influences widespread responses to stress, immune, and inflammatory reactions. [1] Furthermore, metabolic pathways, including amino acid metabolism (e.g., MSRA, SLC6A6, SLC7A5) and cellular respiration (e.g., ME3, COX10), provide the energy and building blocks necessary for maintaining cortical health and function. [4] The COMT (Catechol-O-methyltransferase) gene, involved in dopamine metabolism, also affects frontal lobe function and D1 receptor availability, demonstrating the interconnectedness of these molecular processes. [1]
Genetic Regulation of Cortical Architecture
The genetic landscape significantly influences the development, structure, and ongoing maintenance of the cerebral cortex. Genetic variations, including single nucleotide polymorphisms (SNPs), can impact gene function, regulatory elements, and expression patterns, thereby contributing to individual differences in cortical volume. For instance, specific genes involved in CNS development, such as MOG, PARK2, SH3GL2, ZIC1, CHST9, and JRKL, have been identified in genome-wide association studies related to brain health. [4] Transcription factors like POU3F2, KLF4, and ZIC1 play pivotal roles in regulating gene expression critical for brain development and cellular differentiation. [4]
Beyond protein-coding genes, non-coding RNA molecules can act as crucial regulatory elements. For example, small nuclear RNA (AC078859.13) and small cytoplasmic RNA (AC117462.5) in intergenic regions may regulate the transcription and subsequent expression of genes like ROBO1 and ROBO2, which are important for axonal guidance. [1] The collective influence of these genetic mechanisms, from specific gene functions to broader regulatory networks, dictates the formation and resilience of cortical structures, making them susceptible to changes influenced by genetic predispositions.
Pathophysiological Drivers of Cortical Atrophy
Cortical volume changes, particularly atrophy, are often manifestations of underlying pathophysiological processes that disrupt brain homeostasis. In conditions like Multiple Sclerosis (MS), brain parenchymal volume (nBPV) reduction, T2 lesions, and the presence of "black holes" indicate demyelination and neurodegeneration, leading to measurable cortical volume loss. [4] These processes involve disruptions in cell adhesion, signal transduction, and inflammatory responses, with genes like JAG1 and EGFR implicated in cell migration regulation, which is often disturbed in disease states. [4]
In schizophrenia, cortical volume changes, including those in the corpus callosum and the maldistribution of interstitial neurons in prefrontal white matter, point to a neurodevelopmental origin. [1] Overactivation of the HPA axis and chronic stress contribute to prefrontal cortical impairment, influencing cortical structure and function. [1] The interplay of genetic susceptibilities, such as epistatic interactions between COMT and other genes, with environmental stressors can further exacerbate these pathophysiological mechanisms, leading to progressive cortical atrophy or other structural alterations. [1]
Neuronal Development and Connectivity Pathways
The intricate architecture of the cortex is shaped by specific developmental pathways, involving genes that guide neuronal migration and axonal connections. For instance, GPC1 (glypican, slit receptor) and ROBO2-ROBO1 are critical for dorsal forebrain development, orchestrating neural precursor migration and the establishment of axonal connectivity within and between hemispheres, particularly guiding axons related to the prefrontal cortices. [1] Relatedly, SLIT2, which encodes a secreted protein with conserved protein-protein interaction domains, contributes to migratory mechanisms vital for cellular organization and is evolutionarily conserved, underscoring its fundamental role in neurodevelopment. [5]
Further contributing to cortical maturation, CTXN3 (cortexin) is an integral membrane protein highly enriched in the cortex, with its expression increasing significantly during the perinatal period. This suggests its involvement in the final stages of cortical development and differentiation. Additionally, Neurocan, a brain chondroitin sulfate proteoglycan, plays a role in the extracellular matrix, which is essential for regulating neuronal migration, axon guidance, and synaptic plasticity, all of which are crucial processes influencing the overall structure and volume of the cortex . [1], [9]
Neurotransmitter and Ion Channel Homeostasis
Maintaining a delicate balance of neurotransmission and ion flux is fundamental for neuronal health and the structural integrity of the cortex. The SLC12A2 gene is implicated in the regulation of GABA neurotransmission, the brain's primary inhibitory system, and exhibits differential expression in various contexts. Precise control of GABAergic signaling is vital for neuronal excitability, network stability, and the overall morphology and function of cortical regions. [1]
Polymorphisms in the dopamine D4 receptor are associated with variations in cortical structure, highlighting the significant role of dopaminergic signaling in shaping specific brain areas. Dopamine modulates a wide range of cognitive functions, and the activity of its receptors can influence neuronal plasticity and synaptic integrity, thereby contributing to the observed cortex volume. [10] Furthermore, the CFTR chloride channel is involved in cAMP-dependent Cl- transport, a process crucial for cellular fluid balance and excitability. Proper function of ion channels is essential for maintaining the cellular environment necessary for robust neuronal function and structural stability within the cortex. [5]
Intracellular Signaling and Metabolic Regulation
Intracellular signaling cascades and metabolic pathways are central to the maintenance and plasticity of cortical tissue. The Mitogen-activated protein kinase (MAPK) pathway, whose cascades are controlled by proteins like human tribbles, regulates fundamental cellular processes such as growth, differentiation, and apoptosis. Activation of these pathways directly influences neuronal survival and plasticity, which are key determinants of cortex volume . [5], [11]
Phosphodiesterases PDE4B and PDE5A are involved in regulating cyclic nucleotide signaling, specifically cAMP and cGMP. For example, angiotensin II can increase PDE5A expression in vascular smooth muscle cells, antagonizing cGMP signaling. Such interactions can have broader implications for neurovascular coupling and the metabolic support systems within the cortex, indirectly affecting its volume. [5] Lipid metabolism is also critical, with genes like ANGPTL3 and ANGPTL4 regulating lipid concentrations, essential for cell membrane integrity and signaling. SREBP-2 links isoprenoid and adenosylcobalamin metabolism, crucial for biosynthesis and energy. The GLUT9 (SLC2A9) gene, a facilitative glucose transporter, is vital for glucose uptake, providing the substantial energy required by cortical neurons. Moreover, HMGCR, involved in cholesterol synthesis, has common variants that affect alternative splicing, influencing metabolic flux and cellular integrity . [12], [13], [14], [15], [16], [17], [18]
Genetic Regulation and Disease-Relevant Mechanisms
Genetic regulatory mechanisms, including post-transcriptional control like alternative splicing, play a significant role in determining protein function and expression within the cortex. Common variants in HMGCR, for example, can affect the alternative splicing of exon13, thereby altering metabolic pathways crucial for cortical cell maintenance. Post-translational modifications, such as ubiquitination carried out by ubiquitin ligases like PJA1 (a RING-H2 finger ubiquitin ligase abundantly expressed in the brain), regulate protein stability and activity, profoundly impacting the proteome essential for healthy cortical function . [13], [18], [19]
Dysregulation of these pathways is evident in neurodevelopmental disorders like schizophrenia, where specific genes involved in forebrain development and stress response are implicated in altered cortical structure and function. Chronic stress, for instance, can impair prefrontal cortical cognitive function through hyperdopaminergic mechanisms, suggesting a link between environmental stressors and tangible cortical changes. Such pathway dysregulation highlights potential therapeutic targets aimed at restoring cellular homeostasis and preventing progressive volume alterations within the cortex . [1], [20] Additionally, heat shock protein expression, influenced by genes such as HSPA8, represents a crucial cellular stress response mechanism that protects proteins from damage and ensures their proper folding, thereby maintaining cellular integrity and resilience against stressors that could contribute to neuronal damage and subsequent cortex volume changes. [5]
Diagnostic and Prognostic Utility in Neurological and Psychiatric Disorders
Cortex volume change, often quantified through measures such as normalized brain parenchymal volume (nBPV), serves as a crucial imaging biomarker in the diagnosis and prognosis of various neurological and psychiatric conditions. In diseases like multiple sclerosis, longitudinal measurements of nBPV are utilized to monitor brain atrophy, which is a key indicator of neurodegeneration and disease progression. [4] A significant reduction in cortical volume can predict worse long-term outcomes, including increased disability accumulation and cognitive decline, thereby aiding clinicians in understanding the trajectory of the disease and informing patient and family counseling.
Furthermore, quantitative assessment of gray matter differences, which encompasses cortical volume, holds diagnostic utility in psychiatric disorders like schizophrenia. [21] While initial diagnosis relies heavily on clinical presentation, evidence of specific cortical volume alterations can support the diagnostic process and provide insights into the underlying neuropathology. These structural changes can also prognosticate the severity of cognitive impairment and functional decline, offering a more objective measure to complement behavioral assessments and potentially identifying individuals at risk for more severe disease phenotypes. [22]
Informing Treatment Strategies and Risk Stratification
The quantification of cortex volume change is increasingly relevant for personalizing treatment approaches and stratifying patient risk. In multiple sclerosis, for instance, the rate of brain atrophy, reflected in cortex volume changes, can serve as a marker of treatment response, allowing clinicians to assess the efficacy of disease-modifying therapies and adjust interventions if atrophy continues despite treatment. [4] Identifying individuals with accelerated cortical volume loss can flag those at higher risk for rapid disease progression, warranting more aggressive or alternative therapeutic strategies.
The identification of structural abnormalities, such as in the corpus callosum or prefrontal white matter in schizophrenia, suggests that comprehensive brain morphometry could eventually guide targeted neurotherapeutic or cognitive remediation strategies. [8] Such stratification enables a more precise, individualized medicine approach, moving beyond broad diagnostic categories to address specific neurobiological signatures associated with varying clinical presentations and outcomes.
Elucidating Disease Pathophysiology and Comorbidities
Changes in cortex volume provide critical insights into the underlying pathophysiology of complex brain disorders and their associations with comorbidities. In multiple sclerosis, cortical atrophy is strongly linked to both physical disability and cognitive impairment, highlighting the widespread neurodegenerative processes beyond focal white matter lesions. [4] This understanding helps in recognizing that MS is not solely a white matter disease but also profoundly impacts gray matter, influencing the development of cognitive deficits and other complications.
Similarly, in schizophrenia, structural alterations including gray matter differences and corpus callosum volume changes, suggest dysregulated neurodevelopmental processes and altered neural connectivity. [21] These findings underscore the brain as a complex system where structural integrity is paramount for function, and disruptions can lead to overlapping phenotypes or syndromic presentations. Investigating the genetic underpinnings of these cortical volume changes can further elucidate shared biological pathways between various neurological and psychiatric conditions, aiding in the identification of common risk factors and the development of comprehensive prevention strategies that target fundamental brain health.
References
[1] Potkin, Steven G. et al. "A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype." Schizophrenia Bulletin, vol. 35, no. 5, 2009, pp. 917-27.
[2] Sabatti, Chiara, et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nature Genetics, vol. 41, no. 1, 2009, pp. 35-42.
[3] O'Donnell, Christopher J., et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Medical Genetics, vol. 8, no. 1, 2007, p. S4.
[4] Baranzini, S. E. "Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis." Hum Mol Genet, vol. 18, no. 1, 2009, pp. 764-778.
[5] Vasan, Ramachandran S. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Med Genet, vol. 8, no. 1, 2007, p. S2.
[6] Potkin, Steven G., et al. "A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype." Schizophrenia Bulletin, vol. 34, no. 6, 2008, pp. 1198-1207.
[7] Baranzini, Sergio E. "Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis." Hum Mol Genet, vol. 17, no. 23, 2008, pp. 3852-3860.
[8] Rotarska-Jagiela, A., et al. "The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions." Neuroimage, vol. 39, 2008, pp. 1522–1532.
[9] Rauch, Ursula, et al. "Neurocan: A Brain Chondroitin Sulfate Proteoglycan." Cellular and Molecular Life Sciences CMLS, vol. 58, no. 13, 2001, pp. 1842–1856.
[10] Shaw, P., et al. "Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder." Archives of General Psychiatry, vol. 64, no. 8, 2007, pp. 921-931. PubMed, PMID: 17679632.
[11] Kiss-Toth, Endre, et al. "Human Tribbles, a Protein Family Controlling Mitogen-Activated Protein Kinase Cascades." The Journal of Biological Chemistry, vol. 279, no. 41, 2004, pp. 42703–42708.
[12] Koishi, Ryosuke, et al. "Angptl3 Regulates Lipid Metabolism in Mice." Nature Genetics, vol. 30, no. 2, 2002, pp. 151–157.
[13] Li, Shih-Jen, et al. "The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts." PLoS Genetics, vol. 3, no. 11, 2007, p. e147.
[14] Murphy, Claire, et al. "Regulation by SREBP-2 Defines a Potential Link between Isoprenoid and Adenosylcobalamin Metabolism." Biochemical and Biophysical Research Communications, vol. 355, no. 2, 2007, pp. 359–364.
[15] Phay, Jeanne E., et al. "Cloning and Expression Analysis of a Novel Member of the Facilitative Glucose Transporter Family, SLC2A9 (GLUT9)." Genomics, vol. 66, no. 2, 2000, pp. 217–220.
[16] Romeo, Stefano, et al. "Population-Based Resequencing of ANGPTL4 Uncovers Variations That Reduce Triglycerides and Increase HDL." Nature Genetics, vol. 39, no. 4, 2007, pp. 513–516.
[17] Willer, Cristen J., et al. "Newly Identified Loci That Influence Lipid Concentrations and Risk of Coronary Artery Disease." Nature Genetics, vol. 40, no. 2, 2008, pp. 161–169.
[18] Burkhardt, Richard, et al. "Common SNPs in HMGCR in Micronesians and Whites Associated with LDL-Cholesterol Levels Affect Alternative Splicing of Exon13." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, 2008, pp. 2078–2084.
[19] Yu, Ping, et al. "PJA1, Encoding a RING-H2 Finger Ubiquitin Ligase, Is a Novel Human X Chromosome Gene Abundantly Expressed in Brain." Genomics, vol. 79, no. 6, 2002, pp. 869–874.
[20] Arnsten, Amy F. T., and Patricia S. Goldman-Rakic. "Noise Stress Impairs Prefrontal Cortical Cognitive Function in Monkeys: Evidence for a Hyperdopaminergic Mechanism." Archives of General Psychiatry, vol. 55, no. 4, 1998, pp. 362–368.
[21] Xu, L., et al. "Source-based morphometry: the use of independent component analysis to identify gray matter differences with application to schizophrenia." Hum Brain Mapp, 2008.
[22] Weinberger, D. R., et al. "Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia." Am J Psychiatry, vol. 137, 1980, pp. 1410–1413.